NYSE - Nasdaq Real Time Price USD

Pfizer Inc. (PFE)

26.32

+0.06

(+0.23%)

At close: 4:00 PM EDT

26.30

-0.02

(-0.08%)

After hours: 6:36 PM EDT

Better Buy: Pfizer vs. Viking Therapeutics

These two pharma stocks have followed distinct paths of late. Which is the better investment?

Motley Fool 9 hours ago

PFE
+0.23%
VKTX
Pfizer vs Moderna battle over COVID vaccine patents begins in UK

Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.

Reuters 11 hours ago

MRNA

PFE
+0.23%
BNTX
Pfizer (PFE) Rises Higher Than Market: Key Facts

Pfizer (PFE) reachead $26.26 at the closing of the latest trading day, reflecting a +1% change compared to its last close.

Zacks yesterday

PFE
+0.23%
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options

NEW YORK, April 22, 2024--Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO® (aztreonam-avibactam) for the treatment of adult patients with complicated intra-abdominal infections (cIAI), hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), and complicated urinary tract infections (cUTI), including pyelonephritis. It is also indicated for the treatment of infections due to aerobic Gram-negative

Business Wire yesterday

PFE
+0.23%
11 Best Low Price Pharma Stocks To Invest In

In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]

Insider Monkey 2 days ago

^GSPC

AZN

SWAV
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now

A little up-front investment can go a long way with these three stocks.

Motley Fool 3 days ago

EPD

INTC
-0.38%
PFE
+0.23%
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.

Zacks 4 days ago

PFE
+0.23%
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?

Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?

Investor's Business Daily 5 days ago

PFE
+0.23%
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today

The answer to that question will either make you wince or smile.

Motley Fool 5 days ago

PFE
+0.23%
The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback

Hidden treasures sometimes go overlooked in the busy world of financial markets. Here, attention is frequently drawn to the names with the most sparkle. The purpose of this piece is to highlight three of these less shiny treasures. The first one sticks out for its unwavering dedication to pharmaceutical innovation. The company may grow long term with a strong pipeline driven by cutting-edge technologies like AI and a record year of Food and Drug Administration (FDA) approvals in 2023. The second

InvestorPlace 6 days ago

PFE
+0.23%
WB

BABA
Canaan hires Pfizer executive, reels in $100M for biotech investing

The firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist for Pfizer’s emerging science and innovation unit.

BioPharma Dive 6 days ago

PFE
+0.23%
3 No-Brainer Stocks to Buy With $100 Right Now

A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.

Motley Fool 6 days ago

PFE
+0.23%
COMP

^GSPC
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost in line with estimates. First quarter results came shortly after JNJ’s expansion in the cardiovascular space with the $13.1 billion acquisition of heart device firm Shockwave Medical Inc (NASDAQ: SWAV). First Quarter Highlights For the period ended in March, the healthcare company posted a revenue

Benzinga 7 days ago

JNJ
+0.30%
MRNA

PFE
+0.23%
Why the Market Dipped But Pfizer (PFE) Gained Today

Pfizer (PFE) closed the most recent trading day at $25.91, moving +0.19% from the previous trading session.

Zacks 8 days ago

PFE
+0.23%
^GSPC
Is Pfizer Stock a Buy?

The pharmaceutical giant is laying the groundwork for its next heyday.

Motley Fool 8 days ago

PFE
+0.23%
^GSPC
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.

The average yield from these stocks is more than five times the market average.

Motley Fool 8 days ago

PFE
+0.23%
ARCC

T
+1.16%
10 Micro-Cap Healthcare Stocks Insiders Are Buying

In this article, we will take a detailed look at the 10 Micro-Cap Healthcare Stocks Insiders Are Buying. For a quick overview of such stocks, read our article 5 Micro-Cap Healthcare Stocks Insiders Are Buying. Investors have always been interested in the connection between insider buying and stock returns. Over the past several years there’s been a huge influx […]

Insider Monkey 9 days ago

PTN

DOMH

FLGC
Large Fund Bets Big on Groceries in the Face of Persistent Inflation

Alaska Permanent, the largest U.S. state wealth fund, tripled its investments in Walmart and Kroger.

Barrons.com 9 days ago

WMT
-1.75%
PFE
+0.23%
F
Two Brothers, a Big Biotech Bet and an $8 Billion Payout

Investors in a hedge fund from Baker Bros. Advisors recently received one of the largest windfalls ever following Pfizer’s purchase of Seagen.

The Wall Street Journal 10 days ago

PFE
+0.23%
The Smartest Dividend Stocks to Buy With $400 Right Now

These three stocks are bargains with great dividends.

Motley Fool 10 days ago

EPD

ARCC

PFE
+0.23%

Performance Overview

Return	PFE	S&P 500
YTD	-7.20%	+6.30%
1-Year	-31.18%	+22.67%
3-Year	-23.29%	+22.63%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Pfizer Inc. (PFE)

Better Buy: Pfizer vs. Viking Therapeutics

Pfizer vs Moderna battle over COVID vaccine patents begins in UK

Pfizer (PFE) Rises Higher Than Market: Key Facts

European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options

11 Best Low Price Pharma Stocks To Invest In

3 Stocks Under $50 You Can Buy Hand Over Fist Right Now

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?

If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today

The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback

Canaan hires Pfizer executive, reels in $100M for biotech investing

3 No-Brainer Stocks to Buy With $100 Right Now

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

Why the Market Dipped But Pfizer (PFE) Gained Today

Is Pfizer Stock a Buy?

Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.

10 Micro-Cap Healthcare Stocks Insiders Are Buying

Large Fund Bets Big on Groceries in the Face of Persistent Inflation

Two Brothers, a Big Biotech Bet and an $8 Billion Payout

The Smartest Dividend Stocks to Buy With $400 Right Now

Performance Overview